Samuel Fair Wheeler, DMD Dentist Medicare: Medicare Enrolled Practice Location: 201 N Banks St, Saluda, SC 29138 Phone: 864-445-8124 Fax: 864-445-9504 |
Dr. Scott V. Wellman, DDS Dentist Medicare: Medicare Enrolled Practice Location: 101 R L Sawyer Md Dr, Saluda, SC 29138 Phone: 864-445-8168 |
Kristi Rogers Collins, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 101 R L Sawyer Md Dr, Saluda, SC 29138 Phone: 864-445-8168 Fax: 864-445-2535 |
Christopher Wayne Collins, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 101 R L Sawyer Md Dr, Saluda, SC 29138 Phone: 864-445-8168 Fax: 864-445-2535 |
Dr. Seung Kyu Choi, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 101 R L Sawyer Md Dr, Saluda, SC 29138 Phone: 864-445-8168 Fax: 864-445-2535 |
News Archive
Extending the emergency use of the Pfizer-BioNTech vaccine to preteens and young adolescents adds nearly 17 million more Americans to the pool of those eligible to be immunized against covid-19, helping to build a vaccinated population closer to herd immunity. Moderna and Johnson & Johnson are also testing the efficacy of their vaccines in teens and children.
Time constraints, other illnesses and patient embarrassment may prevent dermatologists, internists and family practitioners from conducting full-body skin examinations, according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals. However, dermatologists are significantly more likely than internists and family practitioners to conduct such screenings.
A new company, Neurotex Ltd, has been established to develop novel silk-based products that have the potential to provide a new generation of nerve repair materials and treatments.
Functional food is the food industry's fastest-growing product group, its leading products including dairy products which contain probiotics, that is, bacteria promoting health. Valio's Lactobacillus rhamnosus GG (LGG®) is the most frequently studied and used probiotic.
Cornerstone Pharmaceuticals Inc., a privately held, clinical stage oncology-focused pharmaceutical company, has announced the closing of its Series B-4 private equity financing of $6,175,000. The Company plans to use the proceeds for its on-going phase I/II clinical trials of its lead cancer drug-CPI-613, research and development, and general corporate purposes.
› Verified 6 days ago